Next Article in Journal
Reduced Risk of Progression from Non-Severe to Severe COVID-19 in Hospitalized Dialysis Patients by Full COVID-19 Vaccination
Next Article in Special Issue
Automated Region of Interest Selection Improves Deep Learning-Based Segmentation of Hyper-Reflective Foci in Optical Coherence Tomography Images
Previous Article in Journal
Evaluation of IL-33R and Galectin-3 as New Biomarkers of Cardiac Damage after Polytrauma—Association with Cardiac Comorbidities and Risk Factors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diabetic Retinopathy and Eye Screening: Diabetic Patients Standpoint, Their Practice, and Barriers; A Cross-Sectional Study

by
Naif Mamdouh Alali
1,
Alanuad Albazei
2,
Horia Mohammed Alotaibi
3,
Ahad Massd Almohammadi
4,
Eilaf Khaled Alsirhani
5,
Turki Saleh Alanazi
6,
Badriah Jariad Alshammri
7,
Mohammed Qasem Alqahtani
8,
Moustafa Magliyah
9,
Shaker Alreshidi
10 and
Hani B. Albalawi
1,*
1
Division of Ophthalmology, Department of Surgery, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia
2
Medical Education Department, King Khaled Eye Specialized Hospital, Riyadh 11462, Saudi Arabia
3
Ophthalmology Department, Imam Abdulrahman bun Faisal University, Damman 34212, Saudi Arabia
4
Pediatric Department, Johns Hopkins Aramco Health Care, Dhahran 34465, Saudi Arabia
5
Ophthalmology Department, King Fahad Specialist Hospital, Tabuk 47913, Saudi Arabia
6
Internal Medicine Department, King Salam Armed Forces Hospital, Tabuk 47512, Saudi Arabia
7
Obstetrics and Gynecology Department, King Salam Armed Forces Hospital, Tabuk 47512, Saudi Arabia
8
Preventive Medicine Department, King Salam Armed Forces Hospital, Tabuk 47512, Saudi Arabia
9
Ophthalmology Department, Prince Mohammed Medical City, Sakakah 42421, Saudi Arabia
10
Ophthalmology Department, Almajmaah University, Almajmaah 15341, Saudi Arabia
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(21), 6351; https://doi.org/10.3390/jcm11216351
Submission received: 9 October 2022 / Revised: 14 October 2022 / Accepted: 25 October 2022 / Published: 27 October 2022

Abstract

:
Diabetes mellites (DM) is one of the most common systemic disorders in Saudi Arabia and worldwide. Diabetic retinopathy (DR) is a potentially blinding ophthalmic consequence of uncontrolled DM. The early detection of DR leads to an earlier intervention, which might be sight-saving. Our aim in this cross-sectional study is to assess patients’ knowledge and practices regarding DR, and to detect the barriers for eye screening and receiving a check-up from an ophthalmologist. The study included 386 diabetic patients. One hundred and thirty-one patients (33.9%) had T1DM and 188 (48.7%) had T2DM. Most of the diabetic patients (73.3%) know that they must have an eye check-up regardless of their blood sugar level. DM was agreed to affect the retina in 80.3% of the patients, 56% of patients agree that DM complications are always symptomatic, and 84.5% know that DM could affect their eyes. The fact that blindness is a complication of diabetic retinopathy was known by 65% of the diabetic patients. A better knowledge was detected among patients older than 50 years of age (54.9%) compared to those aged less than 35 years (40.9%), which was statistically significant (p = 0.030). Additionally, 61.2% of diabetic patients who were university graduates had a significantly better knowledge in comparison to 33.3% of illiterate patients (p = 0.006). Considering the barriers to not getting one’s eyes screened earlier, a lack of knowledge was reported by 38.3% of the patients, followed by lack of access to eye care (24.4%). In conclusion, there is a remarkable increase in the awareness of DR among the Saudi population. This awareness might lead to an earlier detection and management of DR.

1. Introduction

Diabetes mellites (DM) is one of the most common metabolic disorders which affects insulin production or action, such as insulin resistance. It is divided into two types, type 1 DM, in which there is hyperglycemia due to an absolute insulin deficiency, and type 2 DM, which is also characterized by hyperglycemia due to relative deficits in insulin secretion and action [1].
The global prevalence of DM is estimated to be around 8.5% among adults older than 18 years in 2014 [2]. The overall prevalence of DM in Saudi Arabia from 1995–2000 among people who were 30 years or older was 23.7% [3], which is much higher than the worldwide prevalence, indicating that DM is a serious health issue among Saudis.
Diabetic retinopathy (DR) is a retinal consequence of chronic diabetes at the microvascular level. It is one of the most common causes of blindness in diabetic patients. It accounts for about 20% of new blindness incidents among patients who are 45–74 years old [4]. The prevalence of DR among Saudi diabetics is 31% [5]. Types of DR include non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). The American Academy of Ophthalmology’s recommendations for a follow-up of DR are as follows for normal or mild NPDR: every 12 months, for moderate NPDR with clinically significant macular oedema: every 1 month, for severe NPDR without clinically significant macular oedema: every 2 to 4 months, and for severe NPDR with clinically significant macular edema: every 1 month [6]. Regular follow-ups with the ophthalmologist is key to prevent DR progression and blindness and allows for earlier interventions and the management of DR.
A study from the Southern region of Saudi Arabia showed that one third of diabetic patients who has been followed in a diabetic center had DR. Additionally, the study showed that retinopathy is heavily associated with people who were of an older age, had an earlier-onset or longer duration of DM, a poor control of their blood sugar, the use of insulin in their treatment, and the coexistence of hypertension [7]. The aim of this study was to assess diabetic patients’ knowledge and practices regarding RD, and to detect the barriers for eye screening and check-ups with ophthalmologists among diabetic patients in Tabuk, Saudi Arabia.

2. Materials and Methods

This was a cross-sectional study of the knowledge and practices of the diabetic patients of Tabuk, Saudi Arabia regarding DR, as well as the barriers for eye screening and check-ups among the population of Tabuk, Saudi Arabia. It was a hospital-based study at the King Fahad Specialist Hospital Tabuk (KSFH) and King Khaled Hospital (Medical and Surgical wards). The study was conducted by distributing the questionnaires among the patients admitted to the wards or who visited the diabetic centers of the KSFH. The ethical approval was obtained from the University of Tabuk. The research started on 25 June 2019 and the patients who were diagnosed with DM type 1 or type 2 were included. Patients younger than 18 years old were excluded from the study.
Data analysis was performed using statistical software IBM SPSS version 22(SPSS, Inc. Chicago, IL, USA). All statistical analyses were done using the two tailed T-test. A p value less than 0.05 was statistically significant. For the awareness items, each correct answer was scored one point and the total summation of the discrete scores of the different items was calculated. A patient with a score less than 60% (seven points) was considered to have a poor awareness, while a good awareness was considered if they had a score of 60% (eight points or more). Descriptive analyses based on the frequency and percent distribution were done for all variables, including the patients’ demographic data, diabetes clinical data, awareness items, and patients’ practice and source of information. Cross tabulation was used to assess the distribution of one’s awareness according to the patients’ personal and medical data and the source of information. The relations were tested using Pearson’s chi-square test.

3. Results

The study included 386 diabetic patients who were aged between 18 and 65 years. The average age of the patients was 38.7 ± 12.5 years. Among these patients, 203 were females (52.6%) and 147 (38.1%) were university graduated. As for the patients’ monthly income, it was less than 5000 SR (1330 USD) among 161 (41.7%) of the patients. Smoking was reported among 83 (21.5%) of the patients and 63.5% had other co-morbidities including HTN (40.4%), hyperlipidemia (28.8%), and cardiac diseases (15.8%) (Table 1).
Table 2 shows the DM data and related eye diseases among the study’s patients. One hundred and thirty-one patients (33.9%) had T1DM, and 188 (48.7%) had T2DM, while the DM type was unknown for 67 (17.4%) patients. DM was diagnosed 5–10 years earlier in 129 patients (33.4%), while 145 patients (37.6%) had DM for more than 10 years. Oral hypoglycemic medications were used by 202 patients (52.3%), while 172 (44.6%) were on insulin. Checking the blood sugar level at home was reported as “When I feel unwell” among 119 (30.8%) patients, while 88 (22.8%) checked once daily. Ophthalmic diseases were detected in 184 diabetic patients (47.7%) which included cataracts (16.8%), refractive errors (47.3%), and DR (17.9%). Treatments for their eye diseases were received among 117 (63.6%) of those affected.
Table 3 illustrates the diabetic patients’ knowledge regarding diabetes and DR. Most of the diabetic patients (73.3%) knew that they must have eye check-ups regardless of their blood sugar level, and 37.8% knew that diabetics should undergo an eye check-up every year. About half of the studied patients (50.8%) did not believe that they needed to have their eyes checked; they believed this was only necessary when they had symptoms. Additionally, 80.3% of the patients agreed that DM can affect the retina, 56% agreed that diabetic complications are always symptomatic, and 84.5% knew that DM can affect their eyes. The fact that blindness is a complication of diabetic retinopathy was known by 65% of the diabetic patients, but only 26.7% knew that there are available treatments for DR. Blood sugar control as a preventive measure for DR was known by 69.9% of patients, and 53.9% knew that they can prevent DR by a good BP control. Additionally, 75.9% of the studied patients knew that they could prevent DR by a regular visit to the ophthalmologists. In total, 211 (54.7%) of the patients had a good knowledge of DM and DR (Figure 1).
As for the sources of the patients’ information regarding DM and DR (Figure 2), the most reported source was from their doctors (33.9%), followed by their family and friends (24.1%), and the internet and social media (18.4%), while 23.6% had no source of information.
Table 4 demonstrates diabetic patients’ practices regarding their eye check-ups and screening. Among the studied patients, 282 diabetics (73.1%) had their eyes checked before, including 24.8% who had a check-up in the past 2 years, 28% in the past 1 year, and 32.6% in the past 6 months. Additionally, 25.4% of the patients reported that they do eye screening annually. The most reported causes of receiving an eye screening during the past 12 months were not having received any recommendations from their physicians (18.7%), no having enough time (16.6%), having difficulty in reaching an ophthalmologist (9.8%), being asymptomatic (9.3%), and having a lack of information about diabetic eye diseases (8%). Reasons which made patients undergo their first eye screening included a referral from another physician (43.5%), patient’s awareness about the importance of regular eye examinations (15.55), and a knowledge of the risk of DM on the retina (12.4%). Considering the barriers for not receiving an eye screening earlier, a lack of knowledge was reported by 38.3% of the patients, followed by a lack of access to eye care (24.4%), time limitations (16.6%), and a fear of discovering something bad (11.9%), while the cost was among 8.8%.
Table 5 shows patients’ attitudes regarding the physician’s role in encouraging an eye screening. About half of diabetic patients (57.8%) reported that their primary physicians mentioned their need for a regular follow-up in ophthalmology, 58% reported that primary physicians informed them about the effect of diabetes on their eyes, and 58.3% reported that they were advised to go for an ophthalmic screening. Most of the studied patients (72.3%) thought that diabetics need to have an eye check-up when his/her blood sugar level is well-controlled and 67.9% thought that diabetics need to have an eye check-up when his/her blood sugar level is poorly controlled.
Table 6 shows the determinants of patients’ knowledge level regarding DM and DR among diabetic patients. Good knowledge was detected among 54.9% of patients aged more than 50 years compared to 40.9% of those aged less than 35 years with a detected statically significance (p = 0.030). Additionally, 61.2% of university-graduated diabetic patients had a good knowledge in comparison to 33.3% of illiterate patients (p = 0.006). A good knowledge was also reported among 69.5% of type 1 diabetic patients compared to 37.3% of those who were unaware of their DM type (p = 0.001). Diabetics who had DM for more than 10 years had a significantly better knowledge (68.3%) compared to others who were diabetics for less than 5 years (38.4%) (p = 0.001). Additionally, 67.2% of diabetic patients who had their information from their doctors had a good knowledge in comparison to 30.8% of those with no mentioned source (p = 0.001). The majority of diabetic patients who were told by their doctors about the effect of DM on their eyes had a better knowledge (67.9%) in comparison to 36.4% of those who were not (p = 0.001). Additionally, 62.4% of patients who had undergone an eye check-up had a good knowledge versus 33.7% of those who did not (p = 0.001).

4. Discussion

DR is one of the major diabetic complications which can lead to blindness. It is asymptomatic in the early course of the disease. Thus, a screening program for diabetic patients has been implemented for the early detection of the disease and thus the treatment. Patients’ awareness is important for following the recommendations and attending annual screening visits [8]. In this study, a hospital-based, cross-sectional study, which documented the KAP patterns of diabetic patients regarding DR in Tabuk city, included 386 diabetic patients and their ages ranged from 18 to 65 years old. Almost 54.7% of patients with diabetes had a good overall awareness of DM and DR (Figure 1).
Among our participants, 84.5% know that DM could affect their eyes. This is consistent with the findings of studies done in high-income countries. According to Schmid et al., 96% of diabetic patients in Australia were aware that DM might cause vision loss [9], and more than 98% of type 2 DM patients in Japan were aware that DM might cause eye impairment [10]. This level of knowledge is probably due to the improved health care and higher awareness of the importance of the prevention and treatment of DM to reduce the risk of its complications among populations.
DR is a leading cause of preventable vision impairment and blindness, and patients’ awareness and compliance are crucial in preventing DR [8]. This study revealed that diabetic patients had a high level of awareness of DR, with more than 65% know that DR can lead to blindness and 80.3% know that DM can harm the retina. Similar findings were reported by AlHargan et al., who found that more than two-thirds of diabetic patients were aware that DR can lead to blindness and 88% were aware that DM can affect the retina [11]. These results might reflect the efforts made by the health care authorities to raise awareness amongst diabetic patients about DR, as well as the availability of more ophthalmologists on the traditional media, social media, and social campaigns to improve the awareness of the population about diabetic retinopathy.
Only 26.7% of the studied patients knew that there are treatments available for DR. This was similar to a study conducted in the Western region of Saudi Arabia, as more than 34% of subjects were not aware that surgery and laser are treatment options for DR [12]. Another study done in India found comparable gaps in treatment awareness and the need for more proactive outreach efforts [13]. This might indicate the need for more efforts from ophthalmologists to increase the awareness of the population about the different treatment options for DR.
About 56% of the participants believed that diabetic complications are always symptomatic, however 50.8% of diabetics thought that they needed to have their eyes screened even if they were asymptomatic. Moreover, 75.9% of the studied population knew that they could prevent diabetic eye disease by a regular visit to the ophthalmologist. Despite the high level of awareness regarding diabetic eye diseases, knowledge about the frequency was not optimal, with only 37.8% knowing that diabetics should undergo annual eye examinations. This is in line with the findings of previous studies. In Riyadh, Saudi Arabia, 28.7% of diabetics believed that they needed a screening once every year [14], while in Jordan only 20.7% thought that an eye examination should be done annually, [15] and 41.9% of people in Turkey believed that an annual eye check is required [16]. The follow-up frequencies need to be elaborated more by ophthalmologists.
Tight glycemic control is known to influence the occurrence of DR [17]. Among patients in this study, 73.3% knew that diabetics need to have regular eye examinations regardless of their blood sugar level. Blood sugar control as a preventive measure for DR was acknowledged by 69.9% of the patients. These results were different from what was found in Riyadh, as only 22.8% of the respondents there believed that a poor glycemic control was an essential factor that worsens diabetic retinopathy [14]. These results highlight the importance of encouraging patients to adhere to the follow-ups scheduled with their ophthalmologists regardless of the blood sugar levels because DR can be asymptomatic in some patients.
As a part of the metabolic syndrome, hypertension is frequently linked to DM. A high blood pressure increases the risk of both the onset and progression of DM. Blood pressure management in diabetic and hypertensive individuals has been proven to delay the onset of DR [18]. Almost 53.9% of the studied population knew that they could halt the progression of diabetic eye disease by a good BP control. These results indicate that more efforts are needed to elaborate the close connection between blood pressure control and the complications of DM.
When addressing the most reported sources of information, physicians were the providers for 33.9% of participants, followed by family and friends for 24.1%, and the internet and social media for 18.4%, while 23.6% had no source of information. These results are consistent with a previous study conducted in Saudi Arabia which revealed that the most reported source was a physician (44.9%), followed by family and the media by 21.6% and 17.9% of people, respectively [19]. These results indicate the need for a more creative means to deliver information about DM and DR in a faster and more feasible way to the patients, such as via the traditional media, social media, and social campaigns.
Our study population reported that the most common cause of not having their eyes screened during the past 12 months was the lack of a recommendation from their physician (18.7%). On the contrary, the most common reason for diabetics to undergo their first eye screening was their physician’s referral (43.5%), while among the barriers for eye screening, a lack of knowledge was the most reported cause in 38.3% of participants. This can be explained by the limited communication between physicians and patients. Nevertheless, Srinivasan et al.’s study in India showed that also a lack of primary physicians’ recommendations was the most common barrier (38.5%) for a periodic eye check-up (20). In the western region of Saudi Arabia, physicians’ referrals were also the most frequent reason for receiving a first eye screening, while a lack of knowledge was the most frequent barrier to not undergoing an eye screening earlier [20]. On the other hand, the most common reason to not comply with regular follow-ups in Riyadh among 47.1% of diabetics was that “they thought it was not important” [14]. These results show that a patient–physician interaction and good communication skills are still the most influential part of a patients’ knowledge about DR and the need for regular follow-ups.
According to 72.3% of the studied patients, diabetics need to have eye examinations even when his/her blood sugar levels are well-controlled. Similar findings were reported in Riyadh as 75.8% believed that they should follow-up with an ophthalmologist even if their blood sugar was under control. [14] These results indicate that most diabetic patients get enough information about the importance of regular follow-ups once they get their eyes checked up by an ophthalmologist.
Significantly more knowledge was detected among patients older than 50 years (p = 0.030). On the contrary, in Riyadh, it was found that younger age was associated with more knowledge about DM (p < 0.049) [14]. These results might indicate that patients who live in Riyadh, the capital of Saudi Arabia, might have more access to more modern sources of information such as social media and social campaigns, which are commonly accessed by the younger generations. While in other regions, the sources of information might be still more dependent on physicians, who are mostly visited by the elder part of the community.
In this study, 68.3% of diabetics who had diabetes for more than 10 years had significantly more knowledge compared to 38.4% of others who were diabetics for less than 5 years (p = 0.001). Similarly, in India, higher positive attitudes were found among patients with a longer duration of the disease (>5 years) [20]. Meanwhile, AL-Yahya et.al found no significant association with the duration of DM and the level of knowledge [14]. These results indicate that more focus is needed on patients who are newly diabetics to prevent complications or detect them earlier.
The increased awareness of diabetic patients about DR will probably lead to a lower incidence of the advanced disease, especially with the developments in technology and artificial intelligence (AI) [21]. AI can be used as a screening or diagnostic tool. This is accomplished by computer exposure to databases; these can then be used to screen and diagnose. This is implemented in ophthalmology for diseases of a high incidence where an early diagnosis is crucial for treatment, such as in the case of DR, age-related macular degeneration (ARMD), glaucoma, retinopathy of prematurity (ROP), age-related or congenital cataract, and retinal vein occlusion (RVO) [22]. Recent studies suggested that AI can be a useful tool for diabetic retinopathy screening, prediction, and management [23,24,25,26,27]. In an era affected by the COVID-19 pandemic, the value of artificial intelligence and digital health technologies might lead to a more frequent use of AI in DR treatment and management [28]. The only hurdle which remains towards improving the screening and management of DR will become patient awareness and perception about this disease.
To the best of our knowledge, the practice and barriers regarding diabetic retinopathy were not well documented among diabetics [29,30].

5. Conclusions

There is a remarkable increase in the awareness of DR among the Saudi population. This might reflect the efforts made by physicians and healthcare authorities to achieve the goals of preventing the complications of DM and treating them earlier. Efforts to reach these goals might be aided by the new developments in screening and diagnosis tools for DR (such as AI). Achieving these goals will reduce the burdens on the healthcare system and improve the quality of life of the populations.

Author Contributions

Conceptualization, N.M.A.; Data curation, M.M. and H.B.A.; Investigation, A.A., A.M.A. and S.A.; Methodology, H.M.A.; Software, E.K.A., T.S.A. and B.J.A.; Validation, M.Q.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, after approval from the University of Tabuk (READ0052 25/6/2019).

Informed Consent Statement

Informed consent was obtained electronically from the participants after explaining the aims of the study.

Data Availability Statement

All the data presented in this manuscript are available on request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. DeFronzo, R.A. Pathogenesis of type 2 diabetes mellitus. Med. Clin. 2004, 88, 787–835. [Google Scholar] [CrossRef] [PubMed]
  2. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375, 2215–2222. [Google Scholar] [CrossRef] [Green Version]
  3. Al-Nozha, M.M.; Al-Maatouq, M.A.; Al-Mazrou, Y.Y.; Al-Harthi, S.S.; Arafah, M.R.; Khalil, M.Z.; Khan, N.B.; Al-Khadra, A.; Al-Marzouki, K.; Nouh, M.S.; et al. Diabetes mellitus in saudi arabia. Saudi Med. J. 2004, 25, 1603–1610. [Google Scholar] [PubMed]
  4. Kahn, H.A.; Hiller, R. Blindness caused by diabetic retinopathy. Am. J. Ophthalmol. 1974, 78, 58–67. [Google Scholar] [CrossRef]
  5. Elhadd, T.A.; Al-Amoudi, A.A.; Alzahrani, A.S. Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: A review. Ann. Saudi Med. 2007, 27, 241–250. [Google Scholar]
  6. Diabetic retinopathy PPP 2019. Available online: https://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-updated-2017 (accessed on 1 August 2022).
  7. Ahmed, R.A.; Khalil, S.N.; Al-Qahtani, M.A. Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia. J. Family Community Med. 2016, 23, 18–24. [Google Scholar] [CrossRef]
  8. Sabanayagam, C.; Yip, W.; Ting, D.S.; Tan, G.; Wong, T.Y. Ten emerging trends in the epidemiology of diabetic retinopathy. Ophthalmic Epidemiol. 2016, 23, 209–222. [Google Scholar] [CrossRef]
  9. Schmid, K.L.; Schmid, L.M.; Optom, C.P. Knowledge of the ocular effects of diabetes among the general population of Australia and the members of Diabetes Australia. Clin. Exp. Optom. 2003, 86, 91–103. [Google Scholar] [CrossRef] [Green Version]
  10. Funatsu, H.; Hori, S.; Shimizu, E.; Nakamura, S. Questionnaire survey on periodic ocular examination in Japanese diabetic patients. Am. J. Ophthalmol. 2003, 136, 955–957. [Google Scholar] [CrossRef]
  11. AlHargan, M.H.; AlBaker, K.M.; AlFadhel, A.A.; AlGhamdi, M.A.; AlMuammar, S.M.; AlDawood, H.A. Awareness, knowledge, and practices related to diabetic retinopathy among diabetic patients in primary healthcare centers at Riyadh, Saudi Arabia. J. Fam. Med. Prim. Care 2019, 8, 373. [Google Scholar] [CrossRef]
  12. Alzahrani, S.H.; Bakarman, M.A.; Alqahtani, S.M.; Alqahtani, M.S.; Butt, N.S.; Salawati, E.M.; Alkatheri, A.; Malik, A.A.; Saad, K. Awareness of diabetic retinopathy among people with diabetes in Jeddah, Saudi Arabia. Ther. Adv. Endocrinol. Metab. 2018, 9, 103–112. [Google Scholar] [CrossRef]
  13. Namperumalsamy, P.; Kim, R.; Kaliaperumal, K.; Sekar, A.; Karthika, A.; Nirmalan, P.K. A pilot study on awareness of diabetic retinopathy among non-medical persons in South India. The challenge for eye care programmes in the region. Indian J. Ophthalmol. 2004, 52, 247. [Google Scholar] [PubMed]
  14. Al-Yahya, A.; Alsulaiman, A.; Almizel, A.; Barri, A.; Al Adel, F. Knowledge, Attitude, and Practices (KAP) of Diabetics towards Diabetes and Diabetic Retinopathy in Riyadh, Saudi Arabia: Cross-Sectional Study. Clin. Ophthalmol. (Auckl. NZ) 2020, 14, 3187. [Google Scholar] [CrossRef] [PubMed]
  15. Bakkar, M.M.; Haddad, M.F.; Gammoh, Y.S. Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan. Diabetes, metabolic syndrome and obesity: Targets Ther. 2017, 10, 435. [Google Scholar] [CrossRef] [Green Version]
  16. Çetin, E.N.; Zencir, M.; Fenkçi, S.; Akın, F.; Yıldırım, C. Assessment of awareness of diabetic retinopathy and utilization of eye care services among Turkish diabetic patients. Prim. Care Diabetes 2013, 7, 297–302. [Google Scholar] [CrossRef] [PubMed]
  17. Stratton, I.M.; Kohner, E.M.; Aldington, S.J.; Turner, R.C.; Holman, R.R.; Manley, S.E.; Matthews, D.R. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001, 44, 156–163. [Google Scholar] [CrossRef] [Green Version]
  18. Pescosolido, N.; Campagna, O.; Barbato, A. Diabetic retinopathy and pregnancy. Int. Ophthalmol. 2014, 34, 989–997. [Google Scholar] [CrossRef]
  19. Abdulaal, A.E.; Alobaid, O.M.; Alotaibi, A.G.; Aldihan, K.A.; Alnasyan, A.Y.; Albassam, A.A.; AlSenani, M.I.; Alnasyan, A. Diabetic patients’ awareness of diabetic retinopathy symptoms and complications. J. Fam. Med. Prim. Care 2019, 8, 49. [Google Scholar] [CrossRef]
  20. Srinivasan, N.K.; John, D.; Rebekah, G.; Kujur, E.S.; Paul, P.; John, S.S. Diabetes and diabetic retinopathy: Knowledge, attitude, practice (KAP) among diabetic patients in a tertiary eye care centre. J. Clin. Diagn. Res. JCDR 2017, 11, NC01. [Google Scholar] [CrossRef]
  21. Williams, R.; Karuranga, S.; Malanda, B.; Saeedi, P.; Basit, A.; Besançon, S.; Bommer, C.; Esteghamati, A.; Ogurtsova, K.; Zhang, P.; et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2020, 162, 108072. [Google Scholar] [CrossRef] [Green Version]
  22. Padhy, S.K.; Takkar, B.; Chawla, R.; Kumar, A. Artificial intelligence in diabetic retinopathy: A natural step to the future. Indian J. Ophthalmol. 2019, 67, 1004. [Google Scholar] [PubMed]
  23. Gunasekeran, D.V.; Ting, D.S.; Tan, G.S.; Wong, T.Y. Artificial intelligence for diabetic retinopathy screening, prediction and management. Curr. Opin. Ophthalmol. 2020, 31, 357–365. [Google Scholar] [CrossRef] [PubMed]
  24. Bhaskaranand, M.; Ramachandra, C.; Bhat, S.; Cuadros, J.; Nittala, M.G.; Sadda, S.R.; Solanki, K. The value of automated diabetic retinopathy screening with the EyeArt system: A study of more than 100,000 consecutive encounters from people with diabetes. Diabetes Technol. Ther. 2019, 21, 635–643. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Gulshan, V.; Peng, L.; Coram, M.; Stumpe, M.C.; Wu, D.; Narayanaswamy, A.; Venugopalan, S.; Widner, K.; Madams, T.; Cuadros, J.; et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 2016, 316, 2402–2410. [Google Scholar] [CrossRef] [PubMed]
  26. Ting, D.S.W.; Cheung, C.Y.L.; Lim, G.; Tan, G.S.W.; Quang, N.D.; Gan, A.; Hamzah, H.; Garcia-Franco, R.; San Yeo, I.Y.; Lee, S.Y.; et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA 2017, 318, 2211–2223. [Google Scholar] [CrossRef] [PubMed]
  27. Abràmoff, M.D.; Lavin, P.T.; Birch, M.; Shah, N.; Folk, J.C. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit. Med. 2018, 1, 39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Hallak, J.A.; Scanzera, A.C.; Azar, D.T.; Chan, R.V.P. Artificial intelligence in ophthalmology during COVID-19 and in the post COVID-19 era. Curr. Opin. Ophthalmol. 2020, 31, 447–453. [Google Scholar] [CrossRef]
  29. Alatawi, A.; Alali, N.; Alamrani, A.; Hashem, F.; Alhemaidi, S.; Alreshidi, S.; Albalawi, H. Amblyopia and Routine Eye Exam in Children: Parent’s Perspective. Children 2021, 8, 935. [Google Scholar] [CrossRef]
  30. Al-Lahim, W.A.; Al-Ghofaili, R.S.; Mirghani, H.; ALBalawi, H. Evaluation of awareness and attitudes towards common eye diseases among the general population of Northwestern Saudi Arabia. Egypt. J. Hosp. Med. 2018, 70, 1983–1989. [Google Scholar] [CrossRef]
Figure 1. Overall awareness regarding diabetes and diabetic retinopathy among diabetic patients, Tabuk region, Saudi Arabia.
Figure 1. Overall awareness regarding diabetes and diabetic retinopathy among diabetic patients, Tabuk region, Saudi Arabia.
Jcm 11 06351 g001
Figure 2. Source of information regarding diabetes and diabetic retinopathy among diabetic patients, Tabuk region, Saudi Arabia.
Figure 2. Source of information regarding diabetes and diabetic retinopathy among diabetic patients, Tabuk region, Saudi Arabia.
Jcm 11 06351 g002
Table 1. Bio-demographic data of diabetic patients, Tabuk region, Saudi Arabia.
Table 1. Bio-demographic data of diabetic patients, Tabuk region, Saudi Arabia.
Bio-Demographic DataNo%
Age
<356617.1%
35–5015640.4%
>5016442.5%
Gender
Male18347.4%
Female20352.6%
Education
Non educated5113.2%
Basic education6917.9%
High school11930.8%
University/above14738.1%
Monthly income
<5000 SR16141.7%
5000–10,000 SR10928.2%
11,000–20,000 SR8522.0%
>20,000 SR318.0%
Smoking
Yes8321.5%
No30378.5%
Co-morbidities
None14136.5%
HTN15640.4%
Renal disease297.5%
Cardiac diseases6115.8%
Hyperlipemia11128.8%
Rheumatological disease4511.7%
Table 2. Diabetes data and related eye diseases among patients, Tabuk region, Saudi Arabia.
Table 2. Diabetes data and related eye diseases among patients, Tabuk region, Saudi Arabia.
Diabetes DataNo%
Type of diabetes
T1DM13133.9%
T2DM18848.7%
Don’t know6717.4%
Duration of DM (years)
<511229.0%
5–1012933.4%
>1014537.6%
The management of your diabetic
Diet and exercise7920.5%
Oral hypoglycemic drug20252.3%
Insulin17244.6%
Frequency of check of DM at home
When I feel unwell11930.8%
Once a month338.5%
Once a week5313.7%
Once a day8822.8%
More than once a day9324.1%
Do you have eye disease?
Yes18447.7%
No20252.3%
What are the diseases
Cataract3116.8%
Diabetic retinopathy3317.9%
Unknown168.7%
Glaucoma179.2%
Refractive error8747.3%
Receive any treatment for eye disease?
Yes11763.6%
No6736.4%
Table 3. Diabetic patients’ knowledge regarding diabetes and diabetic retinopathy, Tabuk, Saudi Arabia.
Table 3. Diabetic patients’ knowledge regarding diabetes and diabetic retinopathy, Tabuk, Saudi Arabia.
Knowledge ItemsNo%
Do you know that a diabetic patient has to have an eye check-up regardless of blood sugar level?Yes28373.3%
No112.8%
Do not know9223.8%
How frequently should a diabetic patient undergo an eye check-up?Only when vision affected277.0%
Every 2 Years205.2%
Yearly14637.8%
Every 6 months15840.9%
Do not know359.1%
Diabetic patients need to have their eyes checked up only when they have symptoms.Yes14838.3%
No19650.8%
Do not know4210.9%
Diabetes mellites can affect the retina.Yes31080.3%
No225.7%
Do not know5414.0%
The complications of diabetes are always symptomaticYes21656.0%
No7920.5%
Do not know9123.6%
Diabetes could be harmful to the eyes.Yes32684.5%
No215.4%
Do not know3910.1%
Diabetes can lead to blindness.Yes25165.0%
No369.3%
Do not know9925.6%
There are available treatments for Diabetic retinopathy.Yes10326.7%
No4010.4%
Do not know24363.0%
You can prevent Diabetic eye complications by blood sugar control.Yes27069.9%
No205.2%
Do not know9624.9%
You can prevent Diabetic eye disease by regular visits to an ophthalmologist.Yes29375.9%
No297.5%
Do not know6416.6%
You can halt the progression of diabetic eye disease by good blood pressure control.Yes20853.9%
No225.7%
Do not know15640.4%
You can halt the progression of diabetic eye disease by good lipid control.Yes17645.6%
No4110.6%
Do not know16943.8%
Table 4. Diabetic patients practice regarding eye check-up and screening, Tabuk region, Saudi Arabia.
Table 4. Diabetic patients practice regarding eye check-up and screening, Tabuk region, Saudi Arabia.
Patient’s PracticeNo%
Have you had your eyes checked before?Yes28273.1%
No10426.9%
If yes, when was your last visit?2 years ago7024.8%
1 year ago7928.0%
Less than 6 months ago9232.6%
1 month ago269.2%
1 week ago155.3%
How often do you go for an eye screening?I did not visit the doctor17344.8%
Monthly328.3%
Once every six months8321.5%
Yearly9825.4%
If you did not have an eye screening in the past 12 months, what is the reason?I did not receive any recommendations from the doctor7218.7%
I did not have enough time6416.6%
There is a difficulty to reach an ophthalmologist389.8%
I did not have symptoms or vision problems369.3%
I did not have the information about diabetic eye diseases318.0%
Too many other examinations and medical appointments256.5%
I did not have the information about retinal screening236.0%
I am afraid of the examination, result, or treatment143.6%
It is not necessary because my blood sugar is well controlled133.4%
I did not have money112.8%
I feel discomfort during the examination (eye drops, dilated pupils)41.0%
What are the reasons that made you undergo your first eye screening?Doctor’s referral16843.5%
I know the importance of regular eye examination6015.5%
I know the risk of diabetes in the retina4812.4%
What do you think was the biggest barrier for not getting an eye screening earlier?Lack of knowledge14838.3%
Lack of access to eye care9424.4%
Time limitations6416.6%
Fear of discovering something bad4611.9%
Cost/insurance issue348.8%
Table 5. Patients attitude regarding physician’s role and eye screening, Tabuk region, Saudi Arabia.
Table 5. Patients attitude regarding physician’s role and eye screening, Tabuk region, Saudi Arabia.
Physician Role and Patient AttitudeNo%
Did your primary physician mention that you need a regular follow-up for DR?
Yes22357.8%
No16342.2%
Have you been informed by the primary physician about the effect of DM on your eyes?
Yes22458.0%
No16242.0%
Were you advised by your primary physician to go to an ophthalmologist for eye screening?
Yes22558.3%
No16141.7%
Were you formally referred by your primary physician for eye screening?
Yes20051.8%
No18648.2%
Do you think that a diabetic patient needs to have an eye check-up when his/her blood sugar level is well-controlled?
Agree27972.3%
Disagree287.3%
Do not know7920.5%
Do you think that a diabetic patient needs to have an eye check-up when his/her blood sugar level is poorly controlled?
Agree26267.9%
Disagree338.5%
Do not know9123.6%
Table 6. Determinants of patients’ knowledge level regarding diabetes and diabetic retinopathy among diabetic patients, Tabuk region, Saudi Arabia.
Table 6. Determinants of patients’ knowledge level regarding diabetes and diabetic retinopathy among diabetic patients, Tabuk region, Saudi Arabia.
FactorsKnowledge Levelp-Value
PoorGood
No%No%
Age<353959.1%2740.9%0.030 *
35–506239.7%9460.3%
>507445.1%9054.9%
GenderMale7541.0%10859.0%0.103
Female10049.3%10350.7%
EducationNon educated3466.7%1733.3%0.006 *
Basic education3347.8%3652.2%
High school5142.9%6857.1%
University/above5738.8%9061.2%
Duration of DM (years)<56961.6%4338.4%0.001 *
5–106046.5%6953.5%
>104631.7%9968.3%
Type of diabetesT1DM4030.5%9169.5%0.001 *
T2DM9349.5%9550.5%
Do not know4262.7%2537.3%
Frequency of checking the blood sugar at homeWhen I feel unwell5949.6%6050.4%0.732
Once a month1545.5%1854.5%
Once a week2445.3%2954.7%
Once a day4045.5%4854.5%
More than once a day3739.8%5660.2%
Do you have any eye diseases?Yes8244.6%10255.4%0.771
No9346.0%10954.0%
The most common Source for your information about DRNone6369.2%2830.8%0.001 *
Family and friends4346.2%5053.8%
Internet & social media2636.6%4563.4%
Doctors4332.8%8867.2%
Have you been informed by the primary physician about the effect of DM on your eyesYes7232.1%15267.9%0.001 *
No10363.6%5936.4%
Did you have your eyes checked up before?Yes10637.6%17662.4%0.001 *
No6966.3%3533.7%
p: Pearson X2 test; * p < 0.05 (significant).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alali, N.M.; Albazei, A.; Alotaibi, H.M.; Almohammadi, A.M.; Alsirhani, E.K.; Alanazi, T.S.; Alshammri, B.J.; Alqahtani, M.Q.; Magliyah, M.; Alreshidi, S.; et al. Diabetic Retinopathy and Eye Screening: Diabetic Patients Standpoint, Their Practice, and Barriers; A Cross-Sectional Study. J. Clin. Med. 2022, 11, 6351. https://doi.org/10.3390/jcm11216351

AMA Style

Alali NM, Albazei A, Alotaibi HM, Almohammadi AM, Alsirhani EK, Alanazi TS, Alshammri BJ, Alqahtani MQ, Magliyah M, Alreshidi S, et al. Diabetic Retinopathy and Eye Screening: Diabetic Patients Standpoint, Their Practice, and Barriers; A Cross-Sectional Study. Journal of Clinical Medicine. 2022; 11(21):6351. https://doi.org/10.3390/jcm11216351

Chicago/Turabian Style

Alali, Naif Mamdouh, Alanuad Albazei, Horia Mohammed Alotaibi, Ahad Massd Almohammadi, Eilaf Khaled Alsirhani, Turki Saleh Alanazi, Badriah Jariad Alshammri, Mohammed Qasem Alqahtani, Moustafa Magliyah, Shaker Alreshidi, and et al. 2022. "Diabetic Retinopathy and Eye Screening: Diabetic Patients Standpoint, Their Practice, and Barriers; A Cross-Sectional Study" Journal of Clinical Medicine 11, no. 21: 6351. https://doi.org/10.3390/jcm11216351

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop